NEXIEN BIOPHARMA, INC. 10-K Cybersecurity GRC - 2024-10-22

Page last updated on October 23, 2024

NEXIEN BIOPHARMA, INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-10-22 15:00:39 EDT.

Filings

10-K filed on 2024-10-22

NEXIEN BIOPHARMA, INC. filed a 10-K at 2024-10-22 15:00:39 EDT
Accession Number: 0001493152-24-041978

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

ITEM 1C. CYBERSECURITY. The Company recognizes the increasing importance of cybersecurity in today’s digital environment. As a company without active business operations, our current cybersecurity risks are primarily associated with the protection of sensitive company data, including intellectual property and personal information of our personnel and stockholders. The Company has implemented basic cybersecurity measures designed to protect our digital infrastructure and data integrity. These measures include secure data storage solutions, the use of firewalls and antivirus software, and access controls to limit the exposure of sensitive information to unauthorized individuals. We are committed to continually assessing our cybersecurity posture and adapting our strategies to mitigate potential cyber threats. This includes staying informed on the latest cybersecurity trends and threats, as well as best practices for protection. It is important to note that while we strive to protect our digital assets, no cybersecurity measures can guarantee absolute security against all potential cyber incidents. In the event of a cybersecurity breach, the Company is prepared to take appropriate actions to address the incident, mitigate its impact, and comply with applicable regulatory requirements regarding breach notification and reporting. As we advance our business operations, we recognize that our cybersecurity needs may evolve. The Company plans to enhance its cybersecurity measures in line with its business growth and the increasing complexity of cyber threats. This may involve implementing more advanced cybersecurity technologies, engaging external cybersecurity expertise, and developing comprehensive incident response plans. The Company’s board of directors oversees our cybersecurity strategy and risk management, ensuring that cybersecurity remains a priority as our company evolves. We believe that a proactive and adaptive approach to cybersecurity is essential to safeguard our company’s assets, reputation, and the trust of our stockholders.


Company Information

NameNEXIEN BIOPHARMA, INC.
CIK0001625288
SIC DescriptionPharmaceutical Preparations
TickerNXEN - OTC
Website
CategoryNon-accelerated filer
Smaller reporting company
Emerging growth company
Fiscal Year EndJune 29